Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (769)	3/6/2000 3:02:00 AM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 52153

<<Drug delivery is a particularly interesting angle and may be a nice fit with a MLNM. Elan comes to mind.>> Why ELN when they have ALKS in front of their nose? Unless Levin start to wear dark glasses (to much light at MLNM). ALKS is one of the best drug delivery company (small drugs and proteins) what you will found around this days. Bit price now. Also, CEO may be too proud to give up. But, we all have price. Anyway, as long as there continue to be good collaborations fit and maybe few merge, sector may come only stronger, imo. Miljenko